Last Updated : December 10, 2004
Details
FilesGeneric Name:
Agalsidase beta
Project Status:
Complete
Therapeutic Area:
Fabry Disease
Manufacturer:
Genzyme Canada
Brand Name:
Fabrazyme
Project Line:
Reimbursement Review
Project Number:
SR0028-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Resubmission
Indications:
Fabry Disease
Recommendation Type:
Do not list
Final Recommendation:
Recommendation:
Not to list
Files
Last Updated : December 10, 2004